This articlerelies largely or entirely on asingle source. Relevant discussion may be found on thetalk page. Please helpimprove this article byintroducing citations to additional sources. Find sources: "Moprolol" – news ·newspapers ·books ·scholar ·JSTOR(May 2024) |
| Names | |
|---|---|
| IUPAC name 1-(2-Methoxyphenoxy)-3-(propan-2-ylamino)propan-2-ol | |
| Other names (±)-Moprolol | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider | |
| ECHA InfoCard | 100.024.777 |
| EC Number |
|
| MeSH | C009976 |
| UNII | |
| |
| |
| Properties | |
| C13H21NO3 | |
| Molar mass | 239.315 g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Moprolol is abeta-adrenergic antagonist, orbeta blocker. It is typically prescribed to treat hypertension, high blood pressure, angina pectoris, arrhythmias, anxiety, and glaucoma.[1]
Moprolol is currently off the market, most likely due to the manufacturer being in violation of US good manufacturing practices.[1]
Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byexpanding it. |